ClinicalTrials.Veeva

Menu

Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19 (JOCOVID)

G

Groupe Hospitalier Pitie-Salpetriere

Status

Completed

Conditions

COVID-19
Myocarditis
Myocardial Injury

Treatments

Diagnostic Test: Electrocardiogram, transthoracic echocardiography and clinico-biological parameters in routine care

Study type

Observational

Funder types

Other

Identifiers

NCT04320017
CIC1421-20-05

Details and patient eligibility

About

COVID-19 outbreak is often lethal. Mortality has been associated with several cardio-vascular risk factors such as diabetes, obesity, hypertension and tobacco use. Other clinico-biological features predictive of mortality or transfer to Intensive Care Unit are also needed. Cases of myocarditis have also been reported with COVID-19.

Cardio-vascular events have possibly been highly underestimated. The study proposes to systematically collect cardio-vascular data to study the incidence of myocarditis and coronaropathy events during COVID-19 infection.We will also assess predictive factors for transfer in Intensive Care Unit or death.

Enrollment

500 patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • COVID-19 positive patients admitted in a ward identified by positive PCR on nasal swab samples

Exclusion criteria

  • Patients who refused the use of their routine care data after information by investigators.

Trial design

500 participants in 1 patient group

COVID-19 patients
Description:
Patients diagnosed with COVID-19 by PCR done on nasal sample.
Treatment:
Diagnostic Test: Electrocardiogram, transthoracic echocardiography and clinico-biological parameters in routine care

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems